Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma neurotransmitters and functional illness

F Lechin1, B van der Dijs, M E Lechin

  • 1Section of Psychopharmacology, Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela.

Psychotherapy and Psychosomatics
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of bronchial asthma with tianeptine.

Methods and findings in experimental and clinical pharmacology·2005
Same author

Autonomic nervous system assessment throughout the wake-sleep cycle and stress.

Psychosomatic medicine·2004
Same author

Severe asthma and plasma serotonin.

Allergy·2002
Same author

Re: Belohláková et al. Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels. J Appl Physiol 91:755-761, 2001.

Journal of applied physiology (Bethesda, Md. : 1985)·2002
Same author

Asthma, asthma medication and autonomic nervous system dysfunction.

Clinical physiology (Oxford, England)·2001
Same author

Enhancement of noradrenergic neural transmission: an effective therapy of myasthenia gravis: a report on 52 consecutive patients.

Journal of medicine·2001
Same journal

Before Diagnostic Closure: State-Forming Information in Psychiatric Assessment.

Psychotherapy and psychosomatics·2026
Same journal

Schizophrenia Genetic Liability Drives Chronic Disease Risk in Unaffected Individuals Through Immune and Metabolic Pathways.

Psychotherapy and psychosomatics·2026
Same journal

Psychotherapy, Antidepressants, and Combined Treatment for Depression: A Network Meta-analysis on Social Functioning Outcomes.

Psychotherapy and psychosomatics·2026
Same journal

Ketamine-assisted psychotherapy for posttraumatic stress disorder: a systematic review and individual participant data meta-analysis of predictors of treatment effects.

Psychotherapy and psychosomatics·2026
Same journal

Clarifying Scope and Interpretation of Psychotherapeutic Consultation at Work: A Response to Recent Commentary.

Psychotherapy and psychosomatics·2026
Same journal

Efficacy and Moderators of Mindfulness-Based Cognitive Therapy in Difficult-to-Treat Depression: A Systematic Review and Individual Participant Data Meta-Analysis.

Psychotherapy and psychosomatics·2026
See all related articles

Functional illness involves complex brain-body connections, particularly through circulating neurotransmitters. Measuring these peripheral neurochemicals offers insights into central nervous system activity and various diseases.

Area of Science:

  • Neuroscience
  • Psychosomatic Medicine
  • Biochemistry

Background:

  • Functional illness lacks a precise definition despite clinical consensus.
  • The brain-body axis involves neurotransmitters released peripherally into circulation.
  • Central and peripheral neurochemical activities are increasingly linked through research.

Purpose of the Study:

  • To review current scientific literature on functional illness and neurotransmitter disturbances.
  • To explore the relationship between central neurochemistry and peripheral measurements.
  • To highlight the potential of circulating neurotransmitter analysis in understanding disease.

Main Methods:

  • Comprehensive literature review of existing scientific data.
  • Analysis of studies measuring circulating neurotransmitters.

Related Experiment Videos

  • Examination of research linking neurochemical profiles to health and disease states.
  • Main Results:

    • All diseases, including somatic, psychiatric, and psychosomatic, show neurotransmitter disturbances.
    • Measuring circulating neurotransmitters can provide an indirect assessment of central neurochemical profiles.
    • Complete abnormal profiles are established for only a subset of conditions.

    Conclusions:

    • Circulating neurotransmitter measurement offers a promising avenue for understanding functional illness.
    • Challenges in measurement techniques and cost hinder widespread research.
    • Further research is needed to fully establish the diagnostic and therapeutic potential of this approach.